Europe faces substantial challenges in continuing to deliver high-quality healthcare services to its citizens. With growing populations, rigid financing models and rising health inequalities, the conventional, reactive 'sick care' model needs to move to a more proactive, preventative and participatory model of care. Without this transition, by 2040, European healthcare services will face being overwhelmed and unaffordable with diminished access, adversely affecting citizens' health and productivity. Listen to episode 28 of the Life Sciences Connect Podcast to hear our guests dive into the most ..read more

In episode 27 of the Life Sciences Connect Podcast, we speak to the authors of the Time to Change report and discuss the current state of the UK healthcare workforce, touching on topics including pay, diversity, work-life balance, and training.  During our conversation, we explore the unrelenting challenges facing the UK’s healthcare workforce and share actionable, evidence-based solutions to help improve staff wellbeing, recruitment, and retention at a local level ..read more

In Episode 26, our panel of industry experts dive into the key trends and challenges facing the consumer health industry. This is one not to miss. With increased access to information, greater levels of choice and improved functionality of products and technology, consumers are increasingly taking a more proactive role in managing their own health. Tune in for our expert panel’s views on the future of the industry ..read more

Karen and the team explore the findings from the Future of Diagnostic Series   Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging.  ..read more

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend ..read more

The COVID-19 pandemic has brought the Life Sciences Industry to an inflection point. It has exposed the limitations of traditional linear supply chain models, highlighted the need for sustainability and accelerated the move towards digital transformation. Will the COVID-19 pandemic act as a catalyst for biopharma companies to recognise their vulnerabilities and accelerate the digital transformation of their global supply chain models? In the third episode of Life Sciences Connect, we explore the digital transformation of the biopharma supply chain and adoption of AI powered technology.   ..read more

In the second episode of Life Sciences Connect, we explore how the COVID-19 pandemic has accelerated the move towards the Future of Health, where technology and data enable health care that is more personalised, predictive, preventative and participatory.   ..read more

For our first episode, we explore the use of AI technology in clinical trials and how the COVID-19 pandemic is promoting the use of advanced technologies within the biopharma industry. This episode is led by our host Karen Taylor. Karen is joined by Fiona Maini, Principal Global Science and Compliance at Medidata, and Fareed Melham, Head of Acorn AI Labs at Medidata Solutions. This episode covers: How AI technology is currently being used in clinical trials How regulators are embracing AI in clinical development How regulators are changing their approach in response to COVID-19, including in ..read more

In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce. Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State ..read more

On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts: Andy Flockhart, UK MedTech Leader Guido Baechler, CEO of Mainz Biomed And of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role ..read more